Skip to main content
Layla Van Doren, MD, Hematology, New Haven, CT, Yale-New Haven Hospital

LaylaNoheliaVan DorenMD

Hematology • New Haven, CT

Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias

Assistant Professor of Medicine at Yale School of Medicine

Telehealth Available

Request Appointment

Overview of Dr. Van Doren

Dr. Van Doren received her medical degree from George Washington University School of Medicine and Health Sciences. She completed residency at University of Southern California/ Los Angeles County. She then completed Hematology & Oncology fellowship at Tufts Medical Center in Boston, where she served as chief fellow from 2017-2019. Dr. Van Doren’s clinical practice focuses on the diagnosis and management of bleeding and clotting disorders, with a special emphasis in women’s health. She has a particular interest and pregnancy related hematologic disorders, such as hemolytic disease of the fetus (HDFN) and neonatal alloimmune thrombocytopenia (NAIT). Other areas of expertise include difficult-to-manage blood disorders, including antiphospholipid antibody syndrome (APLS), heparin-induced thrombocytopenia (HIT), immune thrombocytopenic purpura (ITP), autoimmune hemolytic anemia (AIHA), and thrombotic thrombocytopenic purpura (TTP).

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2013 - 2016
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 2013
  • Loma Linda University
    Loma Linda UniversityMBA, Healthcare Administration, 2007 - 2009
  • California State University, San Bernardino
    California State University, San BernardinoBachelor of Arts, Art history; minor biology, 2002 - 2007

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2022 - 2024
  • NY State Medical License
    NY State Medical License 2019 - 2022
  • CA State Medical License
    CA State Medical License 2015 - 2022
  • MA State Medical License
    MA State Medical License 2016 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Center for Advanced Training in Hemophilia and Inhibitor Management Nationwide Children's Hospital, 2017
  • 59th annual pre-ASH Trainee Workshop: Building a Career in Hemostasis and Thrombosis Hemostasis and Thrombosis Research Society, 2017

Publications & Presentations

PubMed

Lectures

  • Blockade of Lipid Receptor GPR31 Suppresses Platelet Reactivity and Thrombosis with Minimal Effect on Hemostasis 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Research History

  • Research FellowUnder the guidance of Lidija Covic, PhD, in the Hemostasis and Thrombosis Laboratory, Dr. Van Doren established a mechanistic framework and validated the pathophysiologic and therapeutic relevance of the lipid receptor GPR31 during PAR4-depedant platelet activation.2017 - 2019

Hospital Affiliations

Dr. Layla Van Doren, Dr. Layla Van Doren, MD, Dr. L Van Doren, Dr. Layla Nohelia Van Doren